These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1018 related articles for article (PubMed ID: 37064872)

  • 1. The role of lipid metabolic reprogramming in tumor microenvironment.
    Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
    Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.
    Liu Y; Zhao Y; Song H; Li Y; Liu Z; Ye Z; Zhao J; Wu Y; Tang J; Yao M
    Cancer Lett; 2024 Aug; 597():217076. PubMed ID: 38906524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy.
    Wu Y; Pu X; Wang X; Xu M
    Lipids Health Dis; 2024 Feb; 23(1):35. PubMed ID: 38302980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research Progress and New Immunotherapy Strategies of Tumor Microenvironment Metabolism].
    Peng YM; Luo XM; Chen JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):505-509. PubMed ID: 37248575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer.
    Wang X; Zhou L; Wang H; Chen W; Jiang L; Ming G; Wang J
    Cancer Med; 2023 Nov; 12(21):20573-20589. PubMed ID: 37860928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
    Li L; Ma SR; Yu ZL
    Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
    Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
    J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy.
    Lim SA
    BMB Rep; 2024 Sep; 57(9):388-399. PubMed ID: 38919017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
    Zhang M; Wei T; Zhang X; Guo D
    Front Immunol; 2022; 13():937406. PubMed ID: 36131916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of abnormal lipid metabolism on immune microenvironment in tumors].
    Wu G; Chen Y; Yang Y; Ma M; Huang W; Gao F; Song F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Dec; 37(12):1143-1150. PubMed ID: 34906301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting metabolism to enhance immunotherapy within tumor microenvironment.
    Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X
    Acta Pharmacol Sin; 2024 Oct; 45(10):2011-2022. PubMed ID: 38811773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
    Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
    Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu.
    Wang R; Hu Q; Wu Y; Guan N; Han X; Guan X
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188962. PubMed ID: 37541532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.
    Yu W; Lei Q; Yang L; Qin G; Liu S; Wang D; Ping Y; Zhang Y
    J Hematol Oncol; 2021 Nov; 14(1):187. PubMed ID: 34742349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
    Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
    Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
    Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
    Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Metabolic Reprogramming and Immune Regulation in Digestive Tract Tumors.
    Liu J; Wang T; Zhang W; Huang Y; Wang X; Li Q
    Oncol Res Treat; 2024; 47(6):273-286. PubMed ID: 38636467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma.
    Hu N; Li H; Tao C; Xiao T; Rong W
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
    Huang L; Xu H; Peng G
    Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy.
    Long Y; Shi H; He Y; Qi X
    Front Immunol; 2023; 14():1307228. PubMed ID: 38264667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.